MarketCap
Facebook
X
Telegram
Tenax Therapeutics Shares | TENX
Annual Shares Tenax Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 1967 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.2 M | 15.3 M | 248 K | 28.6 K | 20.6 M | 7.42 M | 6.2 M | 1.56 M | 1.41 M | 1.41 M | 1.4 M | 468 K | 82.5 K | 64.8 K | 58.4 K | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.2 M | 28.6 K | 6.36 M |
Quarterly Shares Tenax Therapeutics
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.9 M | 45.2 M | 39.7 M | 39.6 M | 36.6 M | 3.42 M | 21.2 M | 1.96 M | 1.22 M | 298 K | 23.9 M | 23.9 M | 21.8 M | 2.29 M | 30 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 17.2 M | 14.5 M | 12.6 M | 12.4 M | 9.34 M | 6.97 M | 6.74 M | 6.74 M | 6.39 M | 4.89 M | 3.79 M | 1.46 M | 1.45 M | 1.42 M | 1.41 M | 1.41 M | 1.41 M | 1.41 M | 1.41 M | 28.1 M | 28.1 M | 28.1 M | 28.1 M | 28.1 M | 28.1 M | 28.1 M | 10.3 M | 28.1 M | 28 M | 27.9 M | 1.66 M | 4.94 M | 4.94 M | 2.1 M | 27.6 M | 1.6 M | 32.1 M | 30.2 M | 23.4 M | 23.8 M | 23.8 M | 23.4 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 50.9 M | 298 K | 17.2 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Repare Therapeutics
RPTX
|
42.4 M | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
41.5 M | - | 7.29 % | $ 127 M |  USA |
 |
Windtree Therapeutics
WINT
|
52.6 M | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
51.2 M | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
28.8 M | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
34.6 M | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
2.83 M | - | - | $ 13 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
1.55 M | - | - | $ 24.9 M | USA |
 |
Завод ДИОД
DIOD
|
91.5 M | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
301 M | - | - | - | Russia |
 |
Brickell Biotech
BBI
|
5.39 M | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
140 M | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
44.3 M | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
66.6 M | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
73.8 M | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
64.2 M | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
40.8 M | - | - | $ 2.36 B | USA |
 |
Exicure
XCUR
|
6.3 M | $ 1.09 | 3.81 % | $ 6.86 M | USA |
 |
Cellectis S.A.
CLLS
|
100 M | $ 0.95 | -3.3 % | $ 95.3 M |  France |
 |
AbCellera Biologics
ABCL
|
299 M | $ 12.03 | 1.78 % | $ 3.59 B | Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
134 M | $ 58.93 | 1.57 % | $ 7.88 B | USA |
 |
BioMarin Pharmaceutical
BMRN
|
192 M | $ 55.62 | -0.59 % | $ 10.7 B | USA |
 |
Celldex Therapeutics
CLDX
|
66.4 M | $ 29.48 | 0.79 % | $ 1.96 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
12.2 M | $ 3.75 | 2.18 % | $ 45.8 M |  Israel |
 |
Jaguar Health
JAGX
|
2.33 M | $ 2.36 | 15.44 % | $ 5.5 M | USA |
 |
Protalix BioTherapeutics
PLX
|
78.5 M | $ 2.49 | -2.35 % | $ 196 M | Israel |
 |
uniQure N.V.
QURE
|
57.5 M | $ 21.65 | -3.5 % | $ 1.24 B | Niderland |
 |
Stoke Therapeutics
STOK
|
59.2 M | $ 25.41 | 1.48 % | $ 1.5 B | USA |
 |
Xencor
XNCR
|
74.2 M | $ 29.2 | 15.95 % | $ 2.17 B | USA |
 |
Annexon
ANNX
|
155 M | $ 3.71 | -1.2 % | $ 575 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.65 M | $ 1.71 | -4.21 % | $ 2.82 M | Israel |
 |
Incyte Corporation
INCY
|
195 M | $ 113.3 | -2.08 % | $ 22.1 B | USA |
 |
Mesoblast Limited
MESO
|
1.21 B | $ 12.43 | 1.22 % | $ 15 B |  Australia |
 |
MeiraGTx Holdings plc
MGTX
|
80.4 M | $ 9.2 | -0.16 % | $ 740 M | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
256 M | $ 516.39 | -1.44 % | $ 132 B | USA |
 |
Burford Capital Limited
BUR
|
219 M | $ 3.24 | -3.72 % | $ 710 M |  Britain |
 |
Catalyst Biosciences
CBIO
|
89.3 M | $ 12.77 | -0.39 % | $ 1.14 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
46.7 M | $ 25.47 | 1.29 % | $ 1.19 B | USA |
 |
Anika Therapeutics
ANIK
|
14.3 M | $ 21.19 | -1.07 % | $ 304 M | USA |
 |
Editas Medicine
EDIT
|
88.7 M | $ 2.4 | 0.05 % | $ 213 M | USA |
 |
Evogene Ltd.
EVGN
|
7.87 M | $ 0.37 | 0.44 % | $ 2.91 M | Israel |
 |
EyePoint Pharmaceuticals
EYPT
|
73.3 K | $ 0.36 | -10.09 % | $ 26.4 K | USA |
 |
Fortress Biotech
FBIO
|
27.9 M | $ 1.87 | -3.11 % | $ 52.2 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
28.6 M | $ 10.12 | 0.4 % | $ 289 M | USA |
|
Foghorn Therapeutics
FHTX
|
63 M | $ 2.04 | 2.0 % | $ 128 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
833 M | $ 13.76 | 4.13 % | $ 11.5 B |  India |